Cervical Cancer Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC ®) in Women Living With HIV Aged 15-25 Years
Conditions: Human Papillomavirus Infection Interventions: Biological: Cervavac as three dose regimen; Biological: Cervavac as two dose regimen; Biological: Gardasil as three dose regimen Sponsors: Serum Institute of India Pvt. Ltd.; Bill and Melinda Gates Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Car-cinoma in Women Undergoing Conization
Conditions: Cervical Intraepithelial Neoplasia Grade 2/3; Recurrence Interventions: Biological: vaccination against human papillomavirus infection (HPV vaccination) Sponsors: Charles University, Czech Republic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization
Conditions: Cervical Intraepithelial Neoplasia Grade 2/3; Recurrence Interventions: Biological: vaccination against human papillomavirus infection (HPV vaccination) Sponsors: Charles University, Czech Republic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
Prevalence of HPV (Human Papilloma Virus) and HPV Vaccination Among Victims of Sexual Violence
Conditions: Human Papilloma Virus; Sexual Assault; Sex Abuse Interventions: Diagnostic Test: smears Sponsors: Centre Hospitalier Universitaire Saint Pierre; Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care
Conditions: Human Papillomavirus Infection Interventions: Other: Educational Intervention Sponsors: Roswell Park Cancer Institute; National Cancer Institute (NCI); National Institute on Minority Health and Health Disparities (NIMHD) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
Conditions: Cervical Intraepithelial Neoplasia; Cervical Cancer; Persistent Infection Interventions: Biological: Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli); Other: No intervention; Biological: Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) Sponsors: Xiamen University; Xiamen Innovax Biotech Co., Ltd; Center for Disease Control and Prevention, Sheyang County, Yancheng City, Jiangsu Province, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department
Conditions: Human Papilloma Virus Interventions: Biological: Gardasil 9 Sponsors: University of Alabama at Birmingham; Merck Investigator Studies Program Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
Conditions: Squamous Cell Carcinoma of the Head and Neck; Oropharynx; Human Papillomavirus Viruses; Drug Therapy; Cancer Vaccine Interventions: Drug: Docetaxel; Drug: Cisplatin; Drug: PRGN-2009 Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine
Conditions: Human Papillomavirus Infection Interventions: Biological: Nonavalent HPV study vaccine; Biological: GARDASIL ® 9 Sponsors: Beijing Health Guard Biotechnology, Inc; University of Muhammadiyah Malang Hospital; Dr. M Djamil Hospital, Padang Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2024 Category: Research Source Type: clinical trials
A Phase III Trial to Evaluate the Immunogenicity and Safety of HPV Vaccine
Conditions: Human Papillomavirus Infection Interventions: Biological: nonavalent HPV study vaccine; Biological: GARDASIL ® 9 Sponsors: Beijing Health Guard Biotechnology, Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil ®9 in Young Women
Conditions: Cervical Cancer; Condylomata Acuminata Interventions: Biological: Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli); Biological: Gardasil ®9 Sponsors: Xiamen Ophthalmology Center Affiliated to Xiamen University; Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
HPV Vaccine Reminders - SEARCH II Study
Conditions: Human Papillomavirus Vaccination Interventions: Behavioral: Text Message/automated phone reminder Sponsors: Columbia University; Makerere University; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
Evaluation of Human Papillomavirus Vaccine Coverage in Girls and Young Women With Chronic Disease
Conditions: Human Papillomavirus Vaccine; Chronic Condition Interventions: Other: Questionnaire Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System
Conditions: Vaccine Reaction Interventions: Drug: Gardasil; Drug: Gardasil; Drug: Gardasil; Device: PharmaJet Stratis ® Needle-Free Injection System; Device: PharmaJet Tropis® Needle-Free Injection System Sponsors: PharmaJet, Inc.; National Institutes of Health (NIH); National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)
Conditions: HPV Infection Interventions: Other: Urine Sample Collection; Other: Self-collected Vaginal Swab; Other: Blood Samples Sponsors: International Vaccine Institute; London School of Hygiene and Tropical Medicine; Karolinska Institutet; Centers for Disease Control and Prevention Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials